Edwards Lifesciences | EW - Pre Tax Profit

Stock Price
82.28
Daily Change
-1.18 -1.41%
Monthly
3.50%
Yearly
7.87%
Q2 Forecast
82.35

Edwards Lifesciences reported $348.4M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Artivion USD 11.4M 7.84M Dec/2025
AtriCure USD 2.36M 2.45M Dec/2025
Baxter International USD 121M 12M Sep/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Boston Scientific USD 700M 238M Dec/2025
Cooper Companies USD 116.8M 137.4M Sep/2025
Dexcom USD 300M 58.9M Sep/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Globus Medical USD 143.99M 44.18M Sep/2025
ICU Medical USD 70.3M 36.62M Sep/2025
Inogen USD -6.06M 467K Sep/2024
Insulet USD 140.2M 17.4M Dec/2025
Integra LifeSciences USD -6.82M 524.13M Sep/2025
Intuitive Surgical USD 955.6M 100.4M Dec/2025
J&J USD 7.82B 2.86B Mar/2026
Masimo USD 74.9M 19.5M Sep/2025
Medtronic USD 2.1B 224M Sep/2025
Merit Medical Systems USD 73.18M 29.8M Sep/2025
Stryker USD 1.03B 13M Sep/2025
Tandem Diabetes Care USD -25.14M 32.58M Sep/2025
Teleflex USD -438.58M 573.82M Sep/2025
Zimmer Biomet Holdings USD 98M 320.7M Dec/2025